EUVIMEDEUVIMED entdecken
Crossref

The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer

Marta Zarzycka, Małgorzata Kotula-Balak, Dorota Gil

Human Cell · 2024

DOI: 10.1007/s13577-024-01053-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Marta Zarzycka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland. marta.zarzycka@uj.edu.pl. Hauptthemen laut MEDLINE: Intercellular Adhesion Molecule-1, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Narodowe Centrum Nauki, Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer is one of the most prevalent cancers worldwide. Moreover, if not optimally treated, bladder cancer is a significant burden on healthcare systems due to multiple recurrences which often require more aggressive therapies. Therefore, targeted anti-cancer therapies, developed based on an in-depth understanding of specific proteins and molecular mechanisms, are promising in cancer treatment. Here, for the first time, we presented the new approaches indicating that intracellular adhesion molecule-1 (ICAM-1) may play a potential role in enhancing therapeutic effectiveness for bladder cancer. In the present study, we presented that ICAM-1 expression as well as its regulation in bladder cancer is strongly correlated with the high expression of N-cadherin. Importantly, the presence of N-cadherin and its regulator-TWIST-1 was abolished when ICAM-1 was silenced. We identified also that ICAM-1 is capable of regulating cellular migration, proliferation, and EMT progression in bladder cancer cells via the N-cadherin/SRC/AKT/GSK-3β/β-catenin signaling axis. Therefore, we propose ICAM-1 as a novel metastatic marker for EMT progression, which may also be used as a therapeutic target in bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intercellular Adhesion Molecule-1Urinary Bladder NeoplasmsHumansCell Line, TumorGlycogen Synthase Kinase 3 betaCadherinsEpithelial-Mesenchymal TransitionCell Movement

Stichwörter der Autor:innen

Bladder cancerEMTICAM-1N-cadherinSRC

Substanzen

Intercellular Adhesion Molecule-1Glycogen Synthase Kinase 3 betaCadherins

Autor:innen und Institutionen

  • Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland. marta.zarzycka@uj.edu.pl.
  • Department of Animal Anatomy and Preclinical Sciences, University Centre of Veterinary Medicine JU-UA, University of Agriculture in Kraków, Mickiewicza 24/28, 30-059, Kraków, Poland.
  • Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland.

Förderung

  • Narodowe Centrum Nauki
  • Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum

Zitieren

APA

Zarzycka, M., Kotula-Balak, M., & Gil, D. (2024). The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer. Human Cell. https://doi.org/10.1007/s13577-024-01053-2

Vancouver

Zarzycka M, Kotula-Balak M, Gil D. The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer. Human Cell. 2024. doi:10.1007/s13577-024-01053-2

BibTeX
@article{Zarzycka2024,
  author = {Zarzycka, Marta and Kotula-Balak, Małgorzata and Gil, Dorota},
  title = {The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01053-2}
}
Kostenlos starten →